Marybeth S. Hughes - Concepedia

Author

Marybeth S. Hughes

National Cancer Institute

Also Known As

M Hughes, M. Hughes, M.S. Hughes, MaryBeth S Hughes, Marybeth Hughes, Marybeth S Hughes, Marybeth S. Hughes

156

Publications

25.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Clinical Center

About

Marybeth S. Hughes is an author at National Cancer Institute specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	8.4K
2	Allergy	4	4	344
3	Health Sciences	3	3	51
4	Public Health	1	1	13
5	African American Studies	1	1	13

Marybeth S. Hughes

Publications

24.9K

Citations

H-Index

Page 1

	Year	Citations
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Science Lymphoid NeoplasiaCell TherapyCancer ImmunosurveillanceMedicineCancer Regression	2006	2.6K
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Clinical Cancer Research	2011	2.1K
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Journal of Clinical Oncology	2014	1.6K
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, Journal of Clinical Oncology	2011	1.6K
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman, Blood	2011	1.4K
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Blood	2009	1.4K
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry, Journal of Clinical Oncology	2008	1.3K
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma Richard E. Royal, Catherine Lévy, Keli Turner, Journal of Immunotherapy ImmunologyPathologyPharmacotherapyImmunotherapeuticsImmunotherapy	2010	1.2K
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy Richard A. Morgan, Nachimuthu Chinnasamy, Daniel Abate‐Daga, Journal of Immunotherapy	2013	1.1K
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis Maria R. Parkhurst, James C. Yang, Russell C. Langan, Molecular Therapy Cancer ImmunosurveillanceAvid T CellsObjective RegressionT-regulatory CellImmunology	2010	995

Page 1